[Federal Register Volume 61, Number 18 (Friday, January 26, 1996)]
[Notices]
[Page 2547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-1326]



=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
February 21-22, 1996. The ACMUI will review the National Academy of 
Sciences, Institute of Medicine (IOM), report and provide comments on 
the possible impacts of the report, including any policy, legislative, 
rulemaking, and guidance issues. The meeting will take place at the 
address provided below. All sessions of the meeting will be open to the 
public.

DATES: The meeting will begin at 8:30 a.m., on February 21 and 22, 
1996.

SUPPLEMENTARY INFORMATION: In January 1994, the NRC contracted with the 
IOM, to conduct an external review of the NRC's medical regulatory 
program, which included a review of the basic regulatory rules, 
policies, practices, and procedures. There were three major goals of 
the study: (1) examination of the overall risk associated with the use 
of ionizing radiation in medicine; (2) examination of the broad policy 
issues that underlie the regulation of the medical uses of 
radioisotopes; and (3) a critical assessment of the current framework 
for the regulation of the medical uses of byproduct material. The NRC 
was seeking specific recommendations on two major issues. First, it 
requested recommendations on a uniform national approach to the 
regulation of ionizing radiation in all medical applications, including 
consideration of how the regulatory authority and responsibility for 
medical devices sold in interstate commerce for application of 
radiation to human beings should be allocated among Federal Government 
agencies and between the Federal and State Governments. Secondly, it 
requested recommendations on appropriate criteria to measure the 
effectiveness of regulatory program(s) needed to protect public health 
and safety. The IOM report provides recommendations to Congress, the 
NRC, the States and the Conference of Radiation Control Program 
Directors. The agenda will include a summary of the IOM findings and 
recommendations; a summary of the staff plan, to date, for analysis of 
the report; and a discussion of the implications and impacts of the 
eight recommendations.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Josephine M. Piccone, Ph.D., U.S. 
Nuclear Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards, MS T8F5, Washington, DC 20555, Telephone (301) 415-7270. 
For administrative information, contact Torre Taylor, (301) 415-7900.

Conduct of the Meeting:

    Barry Siegel, M.D., will chair the meeting. Dr. Siegel will conduct 
the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Josephine M. Piccone (address listed previously), 
by February 16, 1996. The transcript of the meeting will be kept open 
until February 26, 1996, for inclusion of written comments submitted 
after February 16, 1996. Statements must pertain to the topics on the 
agenda for the meeting.
    2. At the meeting, questions from members of the public will be 
permitted at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, NW, Lower Level, Washington, DC 20555 (202) 634-3273, on 
or about March 8, 1996. Minutes of the meeting will be available on or 
about April 5, 1996.
    4. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: January 22, 1996.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 96-1326 Filed 1-25-96; 8:45 am]
BILLING CODE 7590-01-P